Posted on 1/26/21
Why Pfizer's Future Looks Better in 2021
Despite the success of its COVID-19 vaccine program, Pfizer(NYSE:PFE) didn't impress investors with its stock performance last year. That could change going forward, though. In this . . .
Posted on 1/26/21
Merck Gives Up on Coronavirus Vaccines
Pharmaceutical giant Merck (NYSE:MRK) officially threw in the towel on its efforts to develop a COVID-19 vaccine. The company said it's discontinuing the development of two . . .
Posted on 1/26/21
Caladrius Biosciences Closes $25.0 Million Private Placement
BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 1/26/21
Seelos Therapeutics Proposes Public Offering of Common Stock
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that . . .
Posted on 1/26/21
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and guide an anti-tumor . . .
Posted on 1/25/21
Citius Pharmaceuticals Announces $20.0 Million Private Placement
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has entered into securities purchase . . .
Posted on 1/25/21
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine . . .
Posted on 1/25/21
TScan Therapeutics Closes $100 Million Series C Financing
TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies in oncology, today announced the closing of an oversubscribed . . .
Posted on 1/25/21
Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update
PRINCETON, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today . . .
Posted on 1/25/21
What Kind of Deals Is Pfizer Planning for the Next Few Years?
Pfizer(NYSE:PFE) has a long and storied history of deal-making. And the big drugmaker's business development activities aren't likely to fall by the wayside in 2021. In . . .
Posted on 1/25/21
Why Pfizer's Future Looks Better in 2021
Despite the success of its COVID-19 vaccine program, Pfizer(NYSE:PFE) didn't impress investors with its stock performance last year. That could change going forward, though. In this . . .
Posted on 1/22/21
Is Johnson & Johnson a Buy?
Johnson & Johnson (NYSE:JNJ) is a blue-chip pharma stock with annual revenues in the neighborhood of $80 billion -- and that's before considering the potential of . . .
Posted on 1/22/21
Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program
The distribution of coronavirus vaccines in lower-income countries could get a huge boost soon. On Thursday, two sources familiar with the matter told Reuters that Pfizer . . .
Posted on 1/22/21
Caladrius Biosciences Announces $25M Private Placement
BASKING RIDGE, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 1/22/21
Phio Pharmaceuticals Announces $14.0 Million Private Placement
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 1/21/21
OncoSec Medical Prices of $42.0 Million Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/21/21
Synaptogenix Announces $14.0 Million Private Placement
Synaptogenix, Inc. (OTCQX: SNPX), formerly Neurotrope Bioscience, Inc., announced today that it has entered into definitive securities purchase agreements with accredited investors to raise approximately $14.0 million . . .
Posted on 1/21/21
Vestar Capital Partners Makes a Majority Investment in Dr. Praeger's Sensible Foods
Vestar Capital Partners, a leading U.S. middle-market private equity firm, announced today that it has made a majority growth investment into Dr. Praeger's Sensible Foods, a . . .
Posted on 1/21/21
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
WINDSOR, Conn.--(BUSINESS WIRE)--SCA Pharmaceuticals, LLC, has entered into a definitive membership interest purchase agreement with The Vistria Group and Excellere Partners.The Vistria Group and Excellere Partners have . . .
Posted on 1/21/21
Caladrius Biosciences Announces $25.0 Million Private Placement
BASKING RIDGE, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 1/21/21
CorMedix to Begin Trading on the Nasdaq Stock Exchange
BERKELEY HEIGHTS, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 1/21/21
Bridges Consumer Healthcare Portfolio Company of Charlesbank Capital Partners Acquires Clarion Brands from Swander Pace Capital
CHATTANOOGA, Tenn., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Bridges Consumer Healthcare LLC has announced the acquisition of Clarion Brands, LLC, from Swander Pace Capital, adding to its . . .
Posted on 1/21/21
Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant
Vaccine partners Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) released information today that provides new evidence that their COVID-19 vaccine is effective against the B.1.1.7 variant that was . . .
Posted on 1/21/21
OncoSec Medical Proposes Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/20/21
Turnstone Biologics Acquires Novel Cell Therapy Platform
NEW YORK--(BUSINESS WIRE)--Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, today announced that it has acquired California-based Myst Therapeutics, a privately . . .
New York
